1Stuehr DJ. Structure-function aspects in the nitric oxide synthase[J]. Ann Rev Pharmacol Toxicol, 1997 ;37:339-59.
2Yokoyama Y, Nimura Y, Nagino M ,et al. Current understanding of gender dimorphism in hepatic pathophysiology[J]. J Surg Res,2005; 128 ( 1 ) : 147-56.
3Takasu A, Yanagawa Y, Sakamoto T, et al. Therapeutic hypothermia limited to the resuscitation period does not prolong survival after severe hemorrhagic shock in rats[J]. Resuscitation,2005 ;67 (1) :119-26.
4de Vera ME, Shapiro RA, Nussler AK, et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines:initial analysis of the human NOS2 promoter[J]. Proc Natl Acad Sci USA, 1996;93(3) :1054-9.
5Kim YM, de Vera ME, Watkins SC, et al. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression[J]. J Biol Chem, 1997; 272 (2) :1402-11.
6Rivera-Chavez FA, Huerta S, Brown R, et al. Resuscitation from hemorrhagic shock comparing standard hemoglobin-based oxygen carrier (HBOC) -201 versus 7.5% hypertonic HBOC-201 [J]. J Trauma,2007; 63(5) :1113-9.
7Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimate blood loss at obstetric haemorrhage using clinical reconstructions[J]. BJOG,2006; 113 (8) :919-24.
8Thiemermann C, Szabo C, Mitchell JA, et al. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide[ J]. Proc Natl Acad Sci U S A,1993; 90( 1 ) :267-71.
9Zhao KS, Huang X, Liu J, Huang Q, et al. New approach to treatment of shock-restitution of vasoreactivity[J]. Shock ,2002 ; 18 ( 2 ) : 189-92.
10Zingarelli B, Ischimpoulos H ,Salzman AL,et al. Amelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat[J]. Eur J Pharmacol, 1997 ;338 ( 1 ) :55-65.
